Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

682.00p
   
  • Change Today:
      28.00p
  • 52 Week High: 682.00p
  • 52 Week Low: 232.50p
  • Currency: UK Pounds
  • Shares Issued: 120.50m
  • Volume: 401,503
  • Market Cap: £821.79m
  • RiskGrade: 125

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest ShareCast News

Oxford Biomedica acquires US viral vector facility

By Iain Gilbert

Date: Tuesday 07 Oct 2025

(Sharecast News) - Cell and gene therapy outfit Oxford Biomedica said on Tuesday that it had agreed to acquire a viral vector manufacturing site in Rockville, Maryland, from ABL for $60m in cash, expanding its US footprint and strengthening its contract development and manufacturing offering.

OXB Regulatory News

Holding(s) in Company 03-Nov-2025 16:55 RNS
Total Voting Rights 03-Nov-2025 07:00 RNS
Director/PDMR Shareholding 20-Oct-2025 17:54 RNS
Director/PDMR Shareholding 20-Oct-2025 17:13 RNS
Board Change 20-Oct-2025 10:17 RNS

OXB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 682.00p
Change Today 28.00p
% Change 4.28 %
52 Week High 682.00p
52 Week Low 232.50p
Volume 401,503
Shares Issued 120.50m
Market Cap £821.79m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average
17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average
Price Trend
84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average
86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average
Income Not Available
Growth
5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average
24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 04-Nov-2025

Time Volume / Share Price
15:18 114 @ 671.00p
16:47 3,768 @ 659.68p
16:35 92,626 @ 682.00p
16:35 523 @ 682.00p
16:35 159 @ 682.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page